Table 2: Clinical data of patients with PHT and patients without PHT

Parameters

Patients without PHT

Patients with PHT

 

P

Number of patients

24 (40%)

36 (60%)

 

Age (years)

52.6 12

58 10

> 0.05

Sex (n,%)

Male: 32 (53.3%)

Female: 28 (46.7%)

 

13 (21.7%)

11 (18.3%)

 

19 (31.7 %)

17 (28.3%)

 

> 0.05

Etiology of renal disease: (n, %)

Diabetic nephropathy 20(33.3%)

HTN 15 (25%)

Glomerulonephritis 7 (11.7%)

Obstructive uropathy 5 (8.3%)

ADPKD 2 (3.3%)

Ch. Pyelonephritis 5 (8.3%)

Undetermined renal 6 (10%)

 

5 (25%)

5 (33.3%)

4 (57.1%)

2

1

2

6

 

15 (75%)

10 (66.7%)

3 (42.9%)

3

1

3

 

 

> 0.05

Antihypertensives (n, %)

Ca channel blockers

Beta blockers

ACE inhibitors

Antidiabetics (n, %)

Insulin

Valdagliptin

No treatment

Hemodialysis (n, %)

Predialysis CKD patients

Hemodialysis patients

Shunt location (n %)

Brachial

Radial

16 (34.8%)

7(15.8%)

3(6.5%)

6(13%)

 

5(25%)

3(15%)

2(10%)

0

17(56.7%)

7(23.3%)

 

00

7(33.3%)

30 (65.2%)

14(30.4%)

1(2.2%)

15(32.6%)

 

15(75%)

8(40%)

4(20%)

3(15%)

13(43.3%)

23(76.7%)

 

9(100%)

14(66.7%)

 

> 0.05

 

 

 

 

 

> 0.05

 

< 0.005

 

 

< 0.05